GALT
Galectin Therapeutics Inc
3.90$
+4.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Galectin Therapeutics Inc (GALT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -17 | -16 | -16 | -10 | -11 | -21 | -24 | -31 | -33 | -42 | -24 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 4.1 | 3.4 | 2.5 | 1.1 | 4.4 | 1.7 | 1.8 | 2.1 | 2.9 | 2.3 | 2.4 | 1.7 | |
| 4.5 | 3.4 | 2.5 | 1.1 | 4.8 | 1.8 | 1.9 | 2.4 | 2.7 | – | – | – | |
| -1.1 | -0.4 | 2.5 | -0.8 | -1.1 | 0.6 | 0.9 | 3.8 | 5.0 | 4.7 | 2.3 | 0.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.4 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.9 | 0.9 | 0.7 | 1.2 | 0.9 | 0.4 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | |
| 31 | 14 | 5.9 | 0.7 | 15 | 50 | 0.3 | -30 | 0.9 | 0.7 | 0.8 | 0.7 | |
| – | – | – | – | 30 | 30 | 30 | 30 | 10 | 30 | 30 | 21 | |
| 31 | 14 | 5.9 | 3.6 | 15 | 50 | 0.3 | 37 | 10 | 40 | 31 | 26 | |
| 19 | -3.3 | -10 | -12 | 5.2 | 39 | -20 | 13 | -21 | 7.1 | -11 | 2.6 | |
| -12 | -17 | -16 | -16 | -10 | -11 | -21 | -24 | -31 | -33 | -42 | -24 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.